4/A//SEC Filing
Boehm Marcus 4/A
Accession 0001493152-21-015911
CIK 0001349929other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 9:56 PM ET
Size
16.4 KB
Accession
0001493152-21-015911
Insider Transaction Report
Form 4/AAmended
Vyant Bio, Inc.VYNT
Boehm Marcus
Director
Transactions
- Gift
Common Stock, $0.0001 par value
2021-05-05+78,263→ 78,263 total(indirect: By Trust) - Gift
Common Stock, $0.0001 par value
2021-05-10−15,523→ 0 total - Gift
Common Stock, $0.0001 par value
2021-05-10+15,523→ 93,786 total(indirect: By Trust) - Purchase
Common Stock, $0.0001 par value
2021-05-28$3.68/sh+5,000$18,400→ 98,786 total(indirect: By Trust) - Other
Common Stock, $0.0001 par value
2021-03-30+93,786→ 93,786 total - Gift
Common Stock, $0.0001 par value
2021-05-05−78,263→ 15,253 total - Purchase
Common Stock, $0.0001 par value
2021-06-30$3.76/sh+5,000$18,825→ 103,786 total(indirect: By Trust)
Footnotes (4)
- [F1]Pursuant to that certain Agreement and Plan of Merger, dated as of August 21, 2020, as amended, by and among Cancer Genetics, Inc. now known as Vyant Bio, Inc. ("Issuer"), CGI Acquisition, Inc., a Minnesota corporation and a wholly-owned subsidiary of Issuer ("Merger Sub") and StemoniX, Inc., a Minnesota corporation ("StemoniX") (the "Merger Agreement"), Reporting Person received shares of the Issuer's common stock, $0.0001 par value (the "Common Stock") in exchange shares of StemoniX common stock, $0.0001 owned prior to the merger.
- [F2]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person under the Boehm Family Trust, Marcus & Kimberley Boehm Trustees on May 24, 2021.
- [F3]Shares were previously reported as being directly held by reporting person.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.70 to $3.8099 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Documents
Issuer
Vyant Bio, Inc.
CIK 0001349929
Entity typeother
Related Parties
1- filerCIK 0001850698
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 9:56 PM ET
- Size
- 16.4 KB